Form 4: Cognizant Director Rohleder Receives Stock Units Through Dividend Equivalent Rights

Director Stephen J. Rohleder receives deferred and restricted stock units in Cognizant Technology Solutions Corp. due to dividend equivalent rights.

Summary

• Stephen J. Rohleder, a director at Cognizant Technology Solutions Corp., received deferred stock units and restricted stock units on August 28, 2024, as a result of dividend equivalent rights.
• He received 48.5246 deferred stock units, which are fully vested but settlement is deferred until a change in control, death/disability, or termination of service.
• He also received 31.9486 restricted stock units that are fully vested with deferred settlement under the same conditions as the deferred stock units.
• Additionally, he received 16.122 restricted stock units that will vest on June 4, 2025, with settlement also deferred under the same conditions.
• Following these transactions, Rohleder directly owns 12,482.0752 deferred stock units, 8,218.2714 restricted stock units that are fully vested, and 4,147.122 restricted stock units that will vest on June 4, 2025.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, indicating standard compensation practices. It doesn't contain overtly positive or negative information, hence a neutral sentiment score.

Positives

• The receipt of stock units through dividend equivalent rights indicates the company's commitment to rewarding its directors.
• The deferred settlement of these units aligns the director's interests with the long-term performance of the company.

Future Outlook

The document does not contain specific forward-looking statements, but the deferred settlement of stock units suggests a long-term alignment of interests between the director and the company.

Industry Context

Form 4 filings are standard practice for reporting insider transactions and are common across publicly traded companies. This filing indicates routine compensation practices for Cognizant's directors.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director incentives with company performance.

Key Dates